Search Articles — Sudonull

Search Results

In this project

Copper Tripeptide in Cosmetics: Safe Concentrations and Risks

https://sudonull.com/copper-tripeptide-in-cosmetics-safe-concentrations-and-risks

Why Hyperconcentrations of Copper Tripeptide (10,000 ppm) Are Dangerous and Useless. Scientific Analysis of Mechanisms of Action, Penetration Limits, and Authenticity Verification Methods.

AI agents for crypto market analysis: Reasoning + Action pattern

https://sudonull.com/ai-agents-for-crypto-market-analysis-reasoning-action-pattern

Breakdown of GitHub solutions failures and implementation of an adaptive AI agent for BTC signals. Code on agent-swarm-kit, examples from April 2026. For middle/senior dev — study the pattern and implement.

Lawsuit Perplexity AI: Leak of Queries to Google Meta

https://sudonull.com/lawsuit-perplexity-ai-leak-of-queries-to-google-meta

Class action lawsuit reveals how Perplexity sends user queries to Google and Meta trackers even in incognito. Details of privacy violations and company reactions. Learn the risks for AI search.

From other projects

Moscow Exchange index falls: reasons for decline and forecast

https://ymaho.com/moscow-exchange-index-falls-reasons-for-decline-and-forecast

Analysis of reasons for the Moscow Exchange index fall of 0.4%: OFZ auction failure, Sber dividend gap, oil risks and market forecast. Find out what awaits investors.

Gene therapy AB-1009 for Pompe disease: clinical trial

https://ymaho.com/gene-therapy-ab-1009-for-pompe-disease-clinical-trial

A clinical trial of gene therapy AB-1009 for late-onset Pompe disease (LOPD) has begun. Phase 1 analysis, mechanism of action, risks, and prognosis. Learn more.

FDA to Review Generic Dexmethylphenidate CTx-1301

https://ymaho.com/fda-to-review-generic-dexmethylphenidate-ctx-1301

FDA to Rule on CTx-1301 May 31 — New ADHD Drug with Up to 12 Hours of Action Without Booster Doses. Learn How This Will Change Therapy for Children and Adults.

Vyjuvek gene gel treatment butterfly disease DEB 2026

https://ymaho.com/vyjuvek-gene-gel-treatment-butterfly-disease-deb-2026

UK approves Vyjuvek gene gel for wound treatment in dystrophic epidermolysis bullosa. Efficacy 67% at 6 months. Learn mechanism of action and prospects.

Survodutide in obesity: 13% efficacy in phase 3

https://ymaho.com/survodutide-in-obesity-13-efficacy-in-phase-3

The new dual agonist Survodutide showed 13% weight reduction in patients with obesity without diabetes. Learn about the mechanism of action, side effects, and prospects of the drug.

Fat-burning cola in Japan: new trend 2026

https://ymaho.com/fat-burning-cola-in-japan-new-trend-2026

Analyzing Japanese fat-burning drinks (Coca-Cola Plus, Suntory Tokusui): mechanism of FOSHU action, GLP-1 imitation, and a $45 billion market. Read details.

Premier League Weekend Review: Key Moments and Trends

https://lrivo.com/premier-league-weekend-review-key-moments-and-trends

Analysis of the latest Premier League action: tactical shifts, transfer impacts, and crucial performances shaping the title race and relegation battle.

Trending Now